Data as of Dec 06
| +1.92 / +1.17%|
The 23 analysts offering 12-month price forecasts for Celgene Corp have a median target of 176.00, with a high estimate of 200.00 and a low estimate of 140.00. The median estimate represents a +5.75% increase from the last price of 166.43.
The current consensus among 28 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.